Swipe om te navigeren naar een ander artikel
P. Gal and T. J. Buist contributed equally and should be considered joint first authors.
Pulmonary vein (PV) reconnection is frequently the cause of recurrence of atrial fibrillation (AF) after ablation. The second-generation gold multi-electrode ablation (Gold-MEA) catheter has a new design possibly resulting in improved lesion formation compared with its predecessor. We aimed to determine the association between effective radiofrequency applications with the Gold-MEA catheter and outcome after AF ablation.
50 consecutive patients with paroxysmal AF underwent Gold-MEA (PVAC GOLDTM, Medtronic Inc.) ablation. The Gold-MEA catheter was navigated to the PV ostium by fluoroscopy. Duty-cycled radiofrequency ablations were performed at all PV ostia. Lesions were considered transmural when electrode temperature was >50 °C and power >3 W for >30 seconds. After the ablation procedure, patients visited the outpatient clinic at 3‑month intervals including 24-hour Holter ECGs.
Mean age was 56 years. All PVs were acutely isolated with the Gold-MEA catheter. Procedure time was 111 ± 22 minutes, ablation time was 24 ± 6.7 minutes and fluoroscopy time was 20 ± 8.1 minutes. No procedure-related complications were observed. One year after ablation, 60 % of patients were still free of arrhythmia recurrences after a single PV isolation attempt. The number of transmural lesions was associated with arrhythmia-free survival: 25.0 % in <72 transmural lesions, 64.3 % in 72–108 transmural lesions and 71.4 % in >108 transmural lesions (p = 0.029).
PV isolation can be performed successfully with the Gold-MEA catheter, with a favourable safety profile. Transmurality of lesions was associated with ablation success and may improve AF ablation success.
Calkins H, Kuck KH, Cappato R, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;2012(14):528–606. CrossRef
Hocini M, Kirchhof N, Condie C, Stewart M. P136/80 strong correlation between RF biophysics, contact assessment, and lesion quality in a temperature-controlled, multi-electrode ablation system. Europace. 2014;ii112:2.
Haines DE, Stewart MT, Strunk A, et al. Evaluation of gold/platinum electrode multipolar phased RF ablations in a swine model in vivo: microembolus production and energy delivery performance. Eur Heart J;S33:983.
Medtronic. PVAC® GOLD. Simply smart. Simply precise. Simply better. 2014.
Perrotta L, Bordignon S, Dugo D, Furnkranz A, Chun KJ, Schmidt B. How to learn pulmonary vein isolation with a novel ablation device: learning curve effects using the endoscopic ablation system. J Cardiovasc Electrophysiol. 2014;25:1293–8. PubMed
Verma A, Debruyne P, Nardi S, et al. Evaluation and reduction of asymptomatic cerebral embolism in ablation of atrial fibrillation, but high prevalence of chronic silent infarction: results of the evaluation of reduction of asymptomatic cerebral embolism trial. Circ Arrhythm Electrophysiol. 2013;6:835–42. CrossRefPubMed
Medtronic. PRECISION GOLD post market study in Europe of pulmonary vein ablation catheter (PVAC GOLD). 2014.
Malmborg H, Lonnerholm S, Blomstrom P, Blomstrom-Lundqvist C. Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: a randomized controlled study comparing the clinical outcome and safety; the AF-COR study. Europace. 2013;15:1567–73. CrossRefPubMed
Gal P, Ooms JFW, Ottervanger JP, et al. Pulmonary vein orientation assessment: Is it necessary in patients undergoing contact force sensing guided radiofrequency catheter ablation of atrial fibrillation. Int J Cardiol Heart Vasc. 2015;8:1–5.
- Effective contact and outcome after pulmonary vein isolation in novel circular multi-electrode atrial fibrillation ablation
T. J. Buist
J. J. J. Smit
A. R. Ramdat Misier
P. P. H. M. Delnoy
- Bohn Stafleu van Loghum